Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v7-EN
Language English English
Date Updated 2020-03-27 2020-01-28
Drug Identification Number 02182815 02182815
Brand name COZAAR COZAAR
Common or Proper name losartan potassium tablets losartan potassium tablets
Company Name ORGANON CANADA INC. ORGANON CANADA INC.
Ingredients LOSARTAN POTASSIUM LOSARTAN POTASSIUM
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100TAB 100TAB
ATC code C09CA C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2019-11-22 2019-11-22
Actual start date 2019-11-22 2019-11-22
Estimated end date 2020-03-27 2020-04-03
Actual end date 2020-03-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Back orders were partially released on January 3rd and on February 6th. Back orders were partially released on January 3rd. Back orders will be partially released on February 14th.
Health Canada comments